Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells

This publication has 17 references indexed in Scilit:

• Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries
  European Journal of Pharmacology, 2001
• The molecular pharmacology of CGRP and related peptide receptor subtypes
  Published by Elsevier ,2000
• Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
  British Journal of Pharmacology, 2000
• Calcitonin Gene-Related Peptide is Released from Capsaicin-Sensitive Nerve Fibres and Induces Vasodilatation of Human Cerebral Arteries Concomitant with Activation of Adenylyl Cyclase
  Cephalalgia, 1996
• Human in vivo evidence for trigeminovascular activation in cluster headache Neuropeptide changes and effects of acute attacks therapies
  Brain, 1994
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
  Annals of Neurology, 1990
• Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
  Annals of Neurology, 1988
• Functional role of perivascular peptides in the control of cerebral circulation
  Trends in Neurosciences, 1985
• Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels*
  Acta Physiologica Scandinavica, 1983
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973